WisdoMont Asset Management is an investment Firm.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
WisdoMont Asset Management is a Shengshan Assets is an excellent venture capital and private equity fund management company in China. Shengshan Assets closely monitors investment opportunities in medical health and smart big data under the trend of consumption upgrading.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2018 | Cryofocus Biotech | Series A | 2.9M |
7/2015 | WEFANS | Series A | 0 |
6/2018 | Weihansi Shengwu | Angel Round | 0 |
7/2020 | OBiO Technology | Series C | 28.5M |
5/2017 | Yuan Qu | Series B | 2.9M |
3/2016 | Ruiquan Caring | Angel Round | - |
5/2018 | HeRui BioMed | Series A | 1.6M |
10/2016 | LinkLab | Series B | 3M |
12/2016 | Xsleep | Angel Round | 431.1k |
12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
8/2015 | Gu Xiaofan | Angel Round | 0 |
3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
1/2016 | LinkLab | Series A | 1.5M |
9/2015 | C-doctor | Angel Round | 1.6M |
2/2016 | Nanobubble | Angel Round | 456.1k |
6/2018 | INGEEK | Angel Round | 0 |
5/2017 | Hongfund Financial | Angel Round | 0 |
5/2016 | Tenbent Insurance | Seed Round | 1.5M |
12/2016 | Tenbent Insurance | Series A | 1.5M |
8/2018 | BANGBANG ROBOT | Series A | - |
7/2020 | OBiO Technology | Series C | 0 |
12/2019 | Elpiscience Biopharmaceuticals | Series B | 0 |
3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
12/2018 | Cryofocus Biotech | Series A | 0 |
8/2018 | BANGBANG ROBOT | Series A | - |
6/2018 | Weihansi Shengwu | Angel Round | 0 |
6/2018 | INGEEK | Angel Round | 0 |
5/2018 | HeRui BioMed | Series A | 0 |
5/2017 | Hongfund Financial | Angel Round | 0 |
5/2017 | Yuan Qu | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|